USPTO serial 79211835
KPC
Reviewed by CopyMark Law Group
Reg. 5547785Status 706Registered
- Filing date
- Status date
- Registration date
- Aug 28, 2018
- Examiner
- HETZEL, DANNEAN
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with KPC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Kunming City, Yunnan Province, CN
Kunming City, Yunnan Province, CN
Kunming City, Yunnan Province, CN
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Roman Campos
Roman Campos Muncy, Geissler, Olds & Lowe, P.C.125 S. Royal St.Alexandria, VA 22314United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | medicines for human purposes for the treatment of cardio-cerebrovascular disease, nervous system disease, anti-malaria, diabetes, Rheumatoid arthritis gout; pharmaceutical preparations in the form of injection for the treatment of cardio-cerebrovascular disease, nervous system disease, anti-malaria, diabetes, Rheumatoid arthritis gout; pharmaceutical preparations in the form of tablet for the treatment of cardio-cerebrovascular disease, nervous system disease, anti-malaria, diabetes, Rheumatoid arthritis gout; raw material medicine for the treatment of cardio-cerebrovascular disease, nervous system disease, anti-malaria, diabetes, Rheumatoid arthritis gout; prepared Chinese medicine for the treatment of cardio-cerebrovascular disease, nervous system disease, anti-malaria, diabetes, Rheumatoid arthritis gout; biochemical medicines for the treatment of cardio-cerebrovascular disease, nervous system disease, anti-malaria, diabetes, Rheumatoid arthritis gout; antibiotics for the treatment of cardio-cerebrovascular disease, nervous system disease, anti-malaria, diabetes, Rheumatoid arthritis gout; medicinal pills for slimming purposes; radioactive drugs for the treatment of cardio-cerebrovascular disease, nervous system disease, anti-malaria, diabetes, Rheumatoid arthritis gout; gases for medical purposes for the treatment of cardio-cerebrovascular disease, nervous system disease, anti-malaria, diabetes, Rheumatoid arthritis gout; disinfectants; contact lens cleaning preparations; media for bacteriological cultures; dietetic foods, namely, pasta and crackers adapted for medical use; depuratives; medicines for veterinary purposes for the treatment of cardio-cerebrovascular disease, nervous system disease, anti-malaria, diabetes, Rheumatoid arthritis gout; fungicides for agricultural purposes; antisepsis paper; Chinese medicine filled in bags for the treatment of cardio-cerebrovascular disease, nervous system disease, anti-malaria, diabetes, Rheumatoid arthritis gout | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 1, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 11, 2025 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Feb 11, 2025 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Feb 11, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 23, 2024 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Aug 28, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jan 5, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 13, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 13, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 13, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 12, 2018 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 28, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 28, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 12, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 12, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 8, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 23, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 23, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 23, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 8, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 7, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 7, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 1, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 1, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 29, 2018 | ALIE | ASSIGNED TO LIE | — |
| Apr 23, 2018 | NREV | NOTICE OF REVIVAL - MAILED | — |
| Apr 23, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 23, 2018 | PETG | PETITION TO REVIVE-GRANTED | — |
| Apr 23, 2018 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Feb 21, 2018 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 21, 2018 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 11, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 26, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 26, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 19, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 18, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 18, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 12, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 12, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 6, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |